Willingdon Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$2.38M Sell
11,756
-901
-7% -$197K 0.6% 53
2019
Q4
$3.05M Sell
12,657
-120
-0.9% -$26.5K 0.63% 53
2019
Q3
$2.47M Sell
12,777
-273
-2% -$52.4K 0.54% 68
2019
Q2
$2.4M Buy
13,050
+11
+0.1% +$1.97K 0.56% 65
2019
Q1
$2.48M Buy
13,039
+256
+2% +$48.9K 0.61% 63
2018
Q4
$2.49M Buy
12,783
+30
+0.2% +$5.85K 0.72% 59
2018
Q3
$2.64M Buy
12,753
+30
+0.2% +$5.91K 0.72% 61
2018
Q2
$2.35M Buy
12,723
+637
+5% +$113K 0.72% 63
2018
Q1
$2.06M Buy
12,086
+4,015
+50% +$737K 0.65% 64
2017
Q4
$1.4M Buy
8,071
+1,177
+17% +$208K 0.46% 80
2017
Q3
$1.28M Buy
6,894
+115
+2% +$20.4K 0.47% 73
2017
Q2
$1.17M Buy
6,779
+210
+3% +$34.2K 0.46% 93
2017
Q1
$1.08M Buy
6,569
+949
+17% +$158K 0.44% 86
2016
Q4
$822K Buy
+5,620
New +$846K 0.39% 86

Other funds holding AMGN

Willingdon Wealth Management's AMGN Position: Q1 2020 in Review

Willingdon Wealth Management reduced its Amgen (AMGN) stake by 7.1% in Q1 2020, selling an estimated $197K and leaving 11,756 shares worth $2.38M. The position accounts for 0.6% of the portfolio, ranked #53.

Willingdon Wealth Management first reported a position in AMGN in Q4 2016 and has held it in 14 quarters since. The position peaked at $3.05M in Q4 2019. 2,029 funds tracked by Wall St. Rank hold AMGN as of Q1 2020.

  • Willingdon Wealth Management held 11,756 shares of Amgen worth $2.38M as of Q1 2020.
  • Willingdon Wealth Management sold 901 Amgen shares in Q1 2020, an estimated $197K.
  • Amgen made up 0.6% of Willingdon Wealth Management's portfolio in Q1 2020, its #53 holding.
  • Willingdon Wealth Management first reported a position in Amgen in Q4 2016 and has held it in 14 quarters since.
  • Willingdon Wealth Management's Amgen position peaked at $3.05M in Q4 2019.
  • 2,029 funds tracked by Wall St. Rank held Amgen as of Q1 2020.

Based on Willingdon Wealth Management's 13F filing for Q1 2020, filed 21 Apr 2020.